The exact population prevalence of APS is unknown but it has been estimated that aPL may contribute to 6.1% of cases of pregnancy morbidity, 13.5% of strokes, 11.5% of myocardial infarctions, and 9.5% of deep vein thromboses (DVT) (2). This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.